- Home
- FULC vs LAES Comparison
FULC vs LAES Comparison
Compare FULC & LAES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- LAES
- Stock Information
- Founded
- FULC 2015
- LAES 2022
- Country
- FULC United States
- LAES Switzerland
- Employees
- FULC N/A
- LAES N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- LAES Semiconductors
- Sector
- FULC Health Care
- LAES Technology
- Exchange
- FULC Nasdaq
- LAES Nasdaq
- Market Cap
- FULC 372.2M
- LAES 388.4M
- IPO Year
- FULC 2019
- LAES N/A
- Fundamental
- Price
- FULC $6.40
- LAES $2.60
- Analyst Decision
- FULC Buy
- LAES Strong Buy
- Analyst Count
- FULC 8
- LAES 1
- Target Price
- FULC $7.13
- LAES $6.00
- AVG Volume (30 Days)
- FULC 420.8K
- LAES 4.7M
- Earning Date
- FULC 07-29-2025
- LAES 09-24-2025
- Dividend Yield
- FULC N/A
- LAES N/A
- EPS Growth
- FULC N/A
- LAES N/A
- EPS
- FULC N/A
- LAES N/A
- Revenue
- FULC N/A
- LAES $10,981,000.00
- Revenue This Year
- FULC N/A
- LAES N/A
- Revenue Next Year
- FULC N/A
- LAES N/A
- P/E Ratio
- FULC N/A
- LAES N/A
- Revenue Growth
- FULC 2752.05
- LAES N/A
- 52 Week Low
- FULC $2.32
- LAES $0.31
- 52 Week High
- FULC $9.30
- LAES $11.00
- Technical
- Relative Strength Index (RSI)
- FULC 44.51
- LAES 38.89
- Support Level
- FULC $6.36
- LAES $2.53
- Resistance Level
- FULC $6.75
- LAES $2.67
- Average True Range (ATR)
- FULC 0.30
- LAES 0.13
- MACD
- FULC 0.01
- LAES 0.01
- Stochastic Oscillator
- FULC 19.59
- LAES 39.08
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.